Gene expression profiling in multiple myeloma cells treated with the novel anti-myeloma agents zoledronate and fluvastatin.

被引：0
|
作者：
Molloy, TJ
Cindy, BB
Deng, YM
Spencer, A
Ma, DF
机构：
[1] Alfred Hosp, Myeloma Res Grp, Melbourne, Vic, Australia
[2] St Vincents Hosp, Sydney, NSW 2010, Australia
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5078
引用
下载
收藏
页码：351B / 351B
页数：1
相关论文
共 50 条
  • [21] Genomic stratification of multiple myeloma treated with novel agents
    Jiang, Allan
    Reece, Donna
    Chang, Hong
    LEUKEMIA & LYMPHOMA, 2012, 53 (02) : 202 - 207
  • [22] Global Gene Expression Profiling in the Study of Multiple Myeloma
    John D. Shaughnessy
    International Journal of Hematology, 2003, 77 : 213 - 225
  • [23] Osteoclast Gene Expression Profiling in Multiple Myeloma.
    Moreaux, Jerome
    Hose, Dirk
    Reme, Thierry
    Moine, Philippe
    Mahtouk, Karene
    Moos, Marion
    Requirand, Guilhem
    De Vos, John
    Rossi, Jean Francois
    Goldschmidt, Hartmut
    Klein, Bernard
    BLOOD, 2008, 112 (11) : 945 - 945
  • [24] Global gene expression profiling in the study of multiple myeloma
    Shaughnessy, JD
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2003, 77 (03) : 213 - 225
  • [25] Gene expression profiling as a prognostic tool in multiple myeloma
    Black, Harmony
    Glavey, Siobhan
    CANCER DRUG RESISTANCE, 2021, 4 (04) : 1008 - 1018
  • [26] POMALIDOMIDE ENHANCES THE ACTIVATION OF ANTI-MYELOMA SPECIFIC T CELLS IN HEALTHY DONORS AND MULTIPLE MYELOMA PATIENTS
    Dai, J.
    Neuber, B.
    Engelhardt, M.
    Medenhoff, S.
    Schmitt, M.
    Ho, A. D.
    Goldschmidt, H.
    Hundemer, M.
    HAEMATOLOGICA, 2015, 100 : 78 - 78
  • [27] Gene Expression Profiling of Bone Marrow Endothelial Cells in Patients with Multiple Myeloma
    Ria, Roberto
    Todoerti, Katia
    Berardi, Simona
    Coluccia, Addolorata Maria Luce
    De Luisi, Annunziata
    Mattioli, Michela
    Ronchetti, Domenica
    Morabito, Fortunato
    Guarini, Attilio
    Petrucci, Maria Teresa
    Dammacco, Franco
    Ribatti, Domenico
    Neri, Antonino
    Vacca, Angelo
    CLINICAL CANCER RESEARCH, 2009, 15 (17) : 5369 - 5378
  • [28] Anti-myeloma activity of endogenous and adoptively transferred activated natural killer cells in experimental multiple myeloma model
    Alici, Evren
    Konstantinidis, Kyriakos V.
    Sutlu, Tolga
    Aints, Alar
    Gahrton, Gosta
    Ljunggren, Hans-Gustaf
    Dilber, M. Sirac
    EXPERIMENTAL HEMATOLOGY, 2007, 35 (12) : 1839 - 1846
  • [29] Molecular profiling in patients with plasma cell myeloma treated with novel agents
    Medinger, M.
    Jakab, A.
    Halter, J.
    Heim, D.
    Buser, A.
    Gerull, S.
    Stern, M.
    Passweg, J.
    Oncology Research and Treatment, 2015, 38 : 12 - 12
  • [30] Bortezomib Is More Effective to Side Population of RPMI8226 Myeloma Cells than Classical Anti-myeloma Agents
    Kim, Kyoung Ha
    Cheong, Hee-Jeong
    Lee, Min Young
    Lee, Namsu
    Lee, Kyu-Taek
    Park, Seong Kyu
    Won, Jong-Ho
    ANTICANCER RESEARCH, 2019, 39 (01) : 127 - 133
12345